IQVIA (IQV)
(Delayed Data from NYSE)
$229.84 USD
+2.44 (1.07%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $229.78 -0.06 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$229.84 USD
+2.44 (1.07%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $229.78 -0.06 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum C VGM
Zacks News
Is a Beat in the Cards for First Data (FDC) in Q4 Earnings?
by Zacks Equity Research
First Data's (FDC) fourth-quarter 2018 results are likely to reflect strength across its core merchant acquiring, card issuance, ISV and Clover solutions.
Spotify (SPOT) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Spotify's (SPOT) fourth-quarter 2018 results to reflect growth in revenues and monthly active users (MAUs).
Gartner (IT) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Gartner's (IT) fourth-quarter 2018 results are likely to reflect strength across each of the three business segments - Research, Consulting and Events.
What???s in Store for Booz Allen Hamilton???s (BAH) Q3 Earnings?
by Zacks Equity Research
Booz Allen's (BAH) major focus is on revenue excluding billable expenses as it drives most of its profitability.
4 Business Services Stocks Poised to Beat Earnings Estimates
by Zacks Equity Research
The business services sector continues to benefit from a strong U.S. economy, reduced tax rates, robust manufacturing and non-manufacturing activities.
Aptiv (APTV) to Post Q4 Earnings: How Are Things Shaping Up?
by Zacks Equity Research
Aptiv (APTV) is benefitting from strong demand for its portfolio of technologies and flexible cost structure.
Xerox (XRX) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Xerox's (XRX) fourth-quarter 2018 results to reflect weak post-sale revenues.
Automatic Data Processing (ADP) Q2 Earnings: What's in Store?
by Zacks Equity Research
Lower tax rate, improving operating metrics and acquisitions are expected to drive ADP's second-quarter fiscal 2019 results.
IQV vs. APTV: Which is a Better Technology Services Stock?
by Zacks Equity Research
A faster share price rally in the past year led to a rich valuation for IQVIA (IQV) compared with Aptiv (APTV).
Here's Why You Should Hold on to IQVIA Holdings (IQV) Stock
by Zacks Equity Research
Solid technological suite, strategic collaborations and growth opportunities from emerging markets are major positives for IQVIA Holdings (IQV). However, high debt remains a concern.
IQVIA (IQV) Introduces Multi-Tenant SaaS Safety Solution
by Zacks Equity Research
The new offering is likely to boost IQVIA's (IQV) Technology & Analytics Solutions segment that provides SaaS solutions.
IQVIA Holdings (IQV) Stock Up 17.5% Over a Year: Here's Why
by Zacks Equity Research
IQVIA Holdings (IQV) enjoys a competitive position in the life sciences industry. It looks strong on the back of its solid technological suite.
Here's Why You Should Hold IQVIA Holdings in Your Portfolio
by Zacks Equity Research
IQVIA Holdings' (IQV) strong presence in life sciences industry and technological prowess are positives.
PRA Health Launches PSN to Expand in Pediatric Care, Stock Up
by Zacks Equity Research
PRA Health's (PRAH) Center for Pediatric Clinical Development is likely to enhance pediatric clinical testing and design with the latest move.
IQVIA Holdings Rides on Technological Suite Amid Debt Woes
by Zacks Equity Research
IQVIA Holdings (IQV) continues to serve the life sciences industry with the help of advanced analytics, technology solutions and contract research services. However, high debt remains a major concern.
IQVIA (IQV) Down 5.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
IQVIA Introduces SaaS Based eConsent Tool for Clinical Trials
by Zacks Equity Research
IQVIA's (IQV) latest eConsent tool is likely to boost the Technology & Analytics Solutions segment.
Business Services Stocks' Earnings on Nov 13: SWCH and GDS
by Zacks Equity Research
The Business Services sector benefits from economic growth. Investors interested in stocks from this sector can watch out for third-quarter 2018 earnings reports of SWCH and GDS.
Business Services Stocks' Q3 Earnings on Nov 1: IT, SRCL, WU
by Zacks Equity Research
The business services sector is currently in good shape. Investors interested in stocks from this sector can watch out for third-quarter 2018 earnings reports of IT, SRCL and WU on Nov 1.
Business Services Stocks' Earnings on Oct 31: ADP, APTV, FISV
by Zacks Equity Research
Investors interested in the business services stocks can watch out for earnings reports of ADP, APTV and FISV on Oct 31.
IQVIA (IQV) Beats Q3 Earnings Estimates, Updates '18 View
by Zacks Equity Research
IQVIA Holdings (IQV) third-quarter 2018 earnings and revenues improve on a year-over-year basis.
IQVIA Holdings (IQV) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
IQVIA (IQV) delivered earnings and revenue surprises of 2.16% and 0.50%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
IQVIA Holdings (IQV) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
IQVIA Holdings' (IQV) third-quarter 2018 earnings are likely to benefit from lower tax rates and operating efficiency.
Here's How IQVIA Will Benefit From Genomics England Allaince
by Zacks Equity Research
IQVIA's (IQV) partnership with Genomics England is expected to boost the Technology & Analytics Solutions segment.
Here's Why Investors Should Retain IQVIA Holdings (IQV) Stock
by Zacks Equity Research
IQVIA Holdings (IQV) looks well poised to benefit from expanding global healthcare system.